Merck (MRK) Cost of Revenue (2009 - 2026)

Merck (MRK) has 18 years of Cost of Revenue data on file, last reported at $4.2 billion in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $4.2 billion, up 22.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.2 billion (up 13.84% YoY), and the FY2025 annual result was $16.4 billion, up 7.83% from the prior year.
• Cost of Revenue slipped to $4.2 billion in Q1 2026 per MRK's latest filing, from $5.6 billion in the prior quarter.
• Over five years, Cost of Revenue peaked at $5.6 billion in Q4 2025 and troughed at $3.4 billion in Q1 2025.
• A 5-year average of $4.1 billion and a median of $3.9 billion in 2023 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue jumped 68.18% in 2022, then dropped 27.03% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $3.9 billion in 2022, then grew by 0.8% to $3.9 billion in 2023, then fell by 2.15% to $3.8 billion in 2024, then soared by 45.01% to $5.6 billion in 2025, then retreated by 24.43% to $4.2 billion in 2026.
• Business Quant data shows MRK's Cost of Revenue at $4.2 billion in Q1 2026, $5.6 billion in Q4 2025, and $3.9 billion in Q3 2025.